Clinical Safety

Addressing the risk of sarcopenia in patients using GLP-1 therapies has become a primary objective for researchers developing next-generation metabolic interventions. As the global pharmaceutical industry experiences a seismic shift toward metabolic health, the focus has broadened from achieving

Fear of audit exposure and professional liability continues to cast a chilling effect on providers who might otherwise offer remote medication-assisted treatment. This clinical hesitation persists even as the United States confronts a maternal health emergency where opioid-related overdoses have

The initiative serves as a platform for shared risk and discovery, allowing hospitals to test and refine AI tools in fast-paced, real-world medical environments. On October 1, 2026, twelve of the most prominent healthcare systems in the United States officially partnered with the AI developer Aidoc

For years, surgeons have treated the neck primarily as a structural corridor or a gateway for life-saving cancer interventions, unaware that this narrow passage also functions as the brain's essential metabolic exhaust pipe. A groundbreaking study from Weill Cornell Medicine has revealed that

Introduction The landscape of neurological medicine is shifting rapidly as the U.S. Food and Drug Administration accelerates its evaluation of a potential breakthrough that could redefine how patients manage multiple sclerosis. This news centers on fenebrutinib, an investigational oral therapy that

The discovery of a germline mutation in a prostate cancer patient facilitates cascade testing for family members who may be at risk for breast, pancreatic, or ovarian cancers. This clinical reality highlights the expanding role of genetic identification as a cornerstone of modern oncology, moving